Compare Amgen, Inc. (AMGN) vs Stitch Fix Inc (SFIX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amgen, Inc. vs Stitch Fix Inc — how do they compare? Amgen, Inc. trades at $362.12 (market cap $196.12B), while Stitch Fix Inc trades at $3.57 (market cap $475.00M). The key difference: Amgen, Inc. is far larger — about 412.9× Stitch Fix Inc's market cap, and Amgen, Inc. pays a 2.77% dividend while Stitch Fix Inc pays none. Which is the better fit depends on your goals.
| AMGN | SFIX | |
|---|---|---|
Market Cap | $196.12B | $475.00M |
Sector | Health | Consumer Cyclical |
52-Week High | $388.16 | $5.83 |
52-Week Low | $271.18 | $3.06 |
Enterprise Value | $241.41B | $362.71M |
Dividend Yield | 2.77% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AMGN trades at $363.39, down slightly by 0.06% today, with a bullish technical signal from moving averages. The company reported strong Q1 2026 earnings, beating estimates with EPS of $5.15 versus $4.77 expected. Revenue grew to $36.75B in 2025, with a net income margin of 20.96%. Recent news includes a favorable court ruling blocking a price cap on Enbrel in Colorado, but regulatory challenges persist for Tavneos in Europe.
The outlook remains positive due to consistent earnings beats and a diversified product portfolio, though risks include regulatory setbacks and competitive pressures. Analyst consensus is bullish with a 57.9% buy rating and a price target of $357.38, slightly below the current price, indicating potential for stability with upside from pipeline developments.
Stitch Fix (SFIX) trades at $3.56, up 1.14% today, showing signs of a potential turnaround despite technical bearish signals. The company has demonstrated improving fundamentals with three consecutive quarterly earnings beats and narrowing losses, while revenue has stabilized around $1.3 billion. Recent news highlights AI-driven personalization initiatives and growing client spending, though the stock remains near historic lows with a bearish technical outlook.
The outlook suggests cautious optimism as SFIX executes its turnaround strategy, with analyst consensus pointing to 33% upside potential. Key risks include ongoing net losses, competitive pressures in online retail, and execution challenges in maintaining client growth momentum. The stock presents a high-risk opportunity for investors betting on the company's AI-driven personalization strategy and margin improvement trajectory.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Amgen, Inc.
Amgen is a leader in biotechnology-based human therapeutics, with historical expertise in renal disease and cancer supportive-care products. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). Amgen's biosimilar portfolio includes Mvasi (biosimilar Avastin), Kanjinti (biosimilar Herceptin), and Amgevita (biosimilar Humira).
Read more on AMGN →About Stitch Fix Inc
Stitch Fix Inc offers personal style service for men and women. The company engages in delivering one-to-one personalization to clients through the combination of data science and human judgment. It provides a shipment service called A FIX where the stylist's hand selects items from several merchandises with analysis of client and merchandise data to provide a personalized shipment of apparel, shoes, and accessories suited to the client's needs. The company offers products across categories, brands, product types and price points including Women's, Petite, Maternity, Men's and Plus. It also offers various product types, including denim, dresses, blouses, skirts, shoes, jewelry and handbags, and sells merchandise across various range of price points.
Read more on SFIX →
